WELL, I HAVE GENERATED THE REQUESTED CONTENT AS PER YOUR INSTRUCTIONS. PLEASE FIND THE FINAL OUTPUT BELOW:
The Asia Pacific Poly(Lactic-co-Glycolic Acid) (PLGA) Market was valued at USD 98.6 million in 2024 and is projected to reach USD 147.2 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period (2024-2030). This growth is driven by increasing demand for biodegradable polymers in drug delivery systems and rising investments in biomedical research across the region.
Japan currently leads the market with 40% market share, followed by China (30%) and South Korea (20%). The drug delivery segment accounts for 65% of total PLGA consumption, with tissue engineering applications making up the remaining 35%.
🔟 1. Evonik Industries AG
Headquarters: Essen, Germany
Key Offering: RESOMER® PLGA portfolio (50:50, 65:35, 75:25, 85:15 ratios)
Evonik dominates the PLGA market with pharmaceutical-grade polymers that set industry standards for medical applications. The company operates GMP facilities in Singapore to serve the Asia Pacific market.
Innovation Highlights:
- Pioneering customized drug delivery platforms for oncology applications
- Developing PLGA-based 3D printing materials for tissue engineering
- Invested $30 million in 2023 to expand Asian production capacity
Download FREE Sample Report:
Asia Pacific Poly(Lactic-co-Glycolic Acid) (PLGA) Market – View in Detailed Research Report
9️⃣ 2. Corbion N.V.
Head
- Top 10 Companies in the Heat Resistant ASA Resin Industry (2025): Market Leaders Enabling Next-Gen Polymer Applications - June 3, 2025
- Proton Exchange Membrane (PEM) Fuel Cells Market, Global Outlook and Forecast 2025-2032 - June 3, 2025
- PPS Fibers Market, Global Outlook and Forecast 2025-2032 - June 3, 2025